Evidence map›Paper›PMID 34418987›Full record

Trial reportBMC public health2021

Process evaluation of a brief messaging intervention to improve diabetes treatment adherence in sub-Saharan Africa.

N Leon, H Namadingo, S Cooper, K Bobrow, C Mwantisi, M Nyasulu, N Sicwebu, A Crampin, N Levitt, A Farmer

Open access · goldAbstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

N LeonSouth African Medical Research Council, Fransie van Zyl Drive, 7535, Tygerberg, Cape Town, South Africa. Natalie.leon@mrc.ac.za.ORCID 0000-0001-9392-3426
H NamadingoMalawi Epidemiology and Intervention Research Unit, Lilongwe, Malawi.
S CooperSouth African Medical Research Council, Fransie van Zyl Drive, 7535, Tygerberg, Cape Town, South Africa.
K BobrowChronic Disease Initiative for Africa, University of Cape Town, Cape Town, South Africa.
C MwantisiMalawi Epidemiology and Intervention Research Unit, Lilongwe, Malawi.
M NyasuluMalawi Epidemiology and Intervention Research Unit, Lilongwe, Malawi.
N SicwebuDivision of Social and Behavioural Science, School of Family Medicine and Public Health, University of Cape Town, Cape Town, South Africa.
A CrampinMalawi Epidemiology and Intervention Research Unit, Lilongwe, Malawi.
N LevittChronic Disease Initiative for Africa, University of Cape Town, Cape Town, South Africa.
A FarmerNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Malawi Epidemiology and Intervention Research Unit · MWUniversity of Cape Town · ZASouth African Medical Research Council · ZALondon School of Hygiene & Tropical Medicine · GBUniversity of Oxford · GB

Funding

Medical Research Council MR/M016498/1
6 · The paper itself

Abstract

backgroundThe SMS text Adherence suppoRt for people with type 2 diabetes (StAR2D) intervention is a pragmatic randomised controlled trial, testing the effectiveness of brief text messaging for improving clinical outcomes and medication adherence. The intervention did not impact glycaemic control. We conducted a pre-and post-trial process evaluation alongside the StAR2D study in Malawi and South Africa, exploring the experiences and perceptions of patient participants, to better understand potential underlying reasons for the trial outcomes.

methodsWe employed a qualitative research design, including conducting semi structured in-depth interviews and focus groups at both trial sites. Purposive sampling was used to ensure representation of a wide range of patients with type 2 diabetes with regards to age, gender, ethnicity, language, and duration of diabetes. We interviewed the same participants at baseline and at the end of the trial. We used within-case and across-case thematic analysis to identify key themes.

resultsBrief messages delivered by text were acceptable and useful for addressing informational and support needs for participants. Some participants reported behaviour changes because of the text reminders and advice on a healthy lifestyle. Both participating in the trial and the messages were experienced as a source of support, caring, and motivation. Participants' ability to act on the messages was limited. A common theme was frustration over the lack of ability to effectively control one's blood glucose level. They reported a range of routinised, partial diabetes care adherence behaviours, shaped by complex and interacting individual, social, and health service factors. Participant responses and intervention impact were similar across sites, despite differences in health services.

conclusionThis process evaluation provided context and insight into the factors influencing participants' engagement with the text messaging intervention. The complex context in which patients take their diabetes medication, may explain in part, why brief text messaging may have been insufficient to bring about changes in health outcomes. The scale of need for self-management and health service support, suggests that health system strengthening, and other forms of self-management support should accompany digital communication interventions. (Current Controlled Trials ISRCTN70768808 , registered 03/08/2015.).

Indexed as

Diabetes Mellitus, Type 2Text MessagingHumansMedication AdherenceSouth AfricaTreatment Adherence and ComplianceBrief text messagingDiabetes adherenceDigital healthLow- and middle-income countriesQualitative process evaluationRandomised trialSub-Saharan Africa

Identifiers

PMID34418987
PMCPMC8379852
OpenAlexW3194552243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.